Citations 4

Bacteriuria During Closed Urinary Drainage: An Evaluation of Top-Vented Versus Bag-Vented Systems

Journal of Urology | June 30, 2017 | Volume: 122 | Issue: 1 | Pages: 49-51

10.1016/s0022-5347(17)56246-1 | PMID 379369

Renal Toxicity During Therapy With Gentamicin or Tobramycin

Journal of Urology | June 30, 2017 | Volume: 127 | Issue: 2 | Pages: 393-393

10.1016/s0022-5347(17)53795-7

Acute Cystitis: A Prospective Study of Laboratory Tests and Duration of Therapy

Journal of Urology | June 30, 2017 | Volume: 133 | Issue: 2 | Pages: 345-345

10.1016/s0022-5347(17)48938-5

Nonvalue of Neomycin Instillation after Intermittent Urinary Catheterization

Antimicrobial Agents and Chemotherapy | June 27, 2012 | Volume: 14 | Issue: 3 | Pages: 368-370

10.1128/aac.14.3.368 | PMID 360984

This study evaluated weekly urine cultures of patients with neurogenic bladder disease who underwent intermittent urinary catheterization for bladder retraining. One group of 53 patients in 1974 received regular instillations of 0.1% neomycin after each catheterization. A similar group of 55 patients in 1975 did not receive neomycin and constituted a control group. Distribution of age, sex, diagnosis, and duration of bladder retraining was comparable in both groups. Quantitative bacterial colony counts of 10 4 to 10 5 or greater per ml of urine were considered significant. There was no difference in the incidence of bacteriuria between the neomycin-treated group and the control group (53 versus 49%, respectively), and most patients in each group had colony counts >10 5 /ml. Escherichia coli was seen less frequently in neomycin-treated patients (43.4 versus 62.5%), but a greater percentage of infections due to Pseudomonas aeruginosa , group D streptococci, and yeasts was noted in the neomycin-treated group than in the control group (41.5 versus 22.5%).